Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?-Reference-Cited by-同舟云学术

Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?

Published:2008-01 Issue:6 Volume:70 Page:1174-1178
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Ajonuma Louis Chukwuemeka

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS;Aboulghar;Hum Reprod,2003

2. Estrogen – induced abnormally high cystic fibrosis transmembrane conductance regulator expression results in ovarian hyperstimulation syndrome Mol;Ajonuma;Endocrinol,2005

3. Distribution of epithelial sodium channels (ENaC) subunits and cystic fibrosis transmembrane conductance regulator (CFTR) in murine reproductive tract;Chan;J Membr Biol,2002

4. Induction of ovulation with gonadotropins Br;Crooke;Med Bull,1970

5. Use of intramuscular progesterone versus intravenous albumin for the prevention of ovarian hyperstimulation syndrome;Costabile;Gynecol Obstet Invest,2000

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of cetrorelix in the prevention and treatment of ovarian hyperstimulation syndrome: A prospective case control study;The Journal of Community Health Management;2024-01-15

2. Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial;Gynecological Endocrinology;2023-10-16

3. Are There Ovarian Responsive Indexes That Predict Cumulative Live Birth Rates in Women over 39 Years?;Journal of Clinical Medicine;2022-04-08

4. Does the controlled ovarian stimulation increase the weight of women undergoing IVF treatment?;European Journal of Obstetrics & Gynecology and Reproductive Biology;2021-08

5. Effect of GnRH-antagonist, mifepristone and letrozole on preventing ovarian hyperstimulation syndrome in rat model;Reproductive BioMedicine Online;2021-02